HG-1310

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHG-1310
Drug Alias NameC6orf51 modulator (Human Genome Sciences)CSG-11 modulator (Human Genome Sciences)bA397G5.3 modulator (Human Genome Sciences)HG-1310
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesInflammationImmune System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesInflammationImmune System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A